These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 18382909

  • 1. Treatment of hirsutism with combined pill containing drospirenone.
    Gregoriou O, Papadias K, Konidaris S, Bakalianou K, Salakos N, Vrachnis N, Creatsas G.
    Gynecol Endocrinol; 2008 Apr; 24(4):220-3. PubMed ID: 18382909
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
    Batukan C, Muderris II.
    Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223
    [Abstract] [Full Text] [Related]

  • 3. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
    Lello S, Primavera G, Colonna L, Vittori G, Guardianelli F, Sorge R, Raskovic D.
    Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543
    [Abstract] [Full Text] [Related]

  • 4. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA, Granata A, D'Arrigo F, Arena D, Panacea A, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990 Dec; 21(3):139-41. PubMed ID: 2149912
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effect on skin and hormonal hyperandrogenic manifestations of an oral estroprogestin association containing ethynilestradiol 30 mg and drospirenone 3 mg].
    Lello S, Primavera G, Colonna L, Vittori G, Guardianelli F, Pallotta P, Sorge R, Bilchugova E, Raskovic D.
    Minerva Ginecol; 2008 Jun; 60(3):239-43. PubMed ID: 18547986
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
    Bertoli A, Fusco A, Magnani A, Marini MA, Di Daniele N, Gatti S, Lauro R.
    Exp Clin Endocrinol Diabetes; 1995 Jun; 103(1):15-20. PubMed ID: 7621099
    [Abstract] [Full Text] [Related]

  • 9. Gonadotropin-releasing hormone agonist (GnRH-A) in hirsutism.
    Falsetti L, Pasinetti E, Ceruti D.
    Acta Eur Fertil; 1994 Jun; 25(5):303-6. PubMed ID: 7660719
    [Abstract] [Full Text] [Related]

  • 10. Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.
    De Leo V, Di Sabatino A, Musacchio MC, Morgante G, Scolaro V, Cianci A, Petraglia F.
    Contraception; 2010 Sep; 82(3):276-80. PubMed ID: 20705157
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndrome.
    Pehlivanov B, Mitkov M.
    Eur J Contracept Reprod Health Care; 2007 Mar; 12(1):30-5. PubMed ID: 17455042
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New alternative treatment in hirsutism: bicalutamide 25 mg/day.
    Müderris II, Bayram F, Ozçelik B, Güven M.
    Gynecol Endocrinol; 2002 Feb; 16(1):63-6. PubMed ID: 11915584
    [Abstract] [Full Text] [Related]

  • 15. The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
    van Vloten WA, van Haselen CW, van Zuuren EJ, Gerlinger C, Heithecker R.
    Cutis; 2002 Apr; 69(4 Suppl):2-15. PubMed ID: 12096825
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.
    Bhattacharya SM, Jha A.
    Fertil Steril; 2012 Oct; 98(4):1053-9. PubMed ID: 22795636
    [Abstract] [Full Text] [Related]

  • 17. The androgenic profile of women with non-insulin-dependent diabetes mellitus.
    Tok EC, Ertunc D, Evruke C, Dilek S.
    J Reprod Med; 2004 Sep; 49(9):746-52. PubMed ID: 15493567
    [Abstract] [Full Text] [Related]

  • 18. [Use of yasmin in the treatment of women with polycystic ovary syndrome].
    Pekhlivanov B, Mitkov M, Ivancheva Kh, Amaliev I.
    Akush Ginekol (Sofiia); 2006 Sep; 45(3):25-9. PubMed ID: 16889184
    [Abstract] [Full Text] [Related]

  • 19. Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism.
    Batukan C, Muderris II, Ozcelik B, Ozturk A.
    Gynecol Endocrinol; 2007 Jan; 23(1):38-44. PubMed ID: 17484511
    [Abstract] [Full Text] [Related]

  • 20. SHBG, testosterone, androstenedione, 17-OH-Progesterone plasma levels in PCO affected women treated with a triphasic oral contraceptive.
    Negri P, Agnello G, Borghesani F, Tomain L, Minisci N, D'Errico G, Cavallini AR.
    Acta Eur Fertil; 1987 Jan; 18(6):375-80. PubMed ID: 3454501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.